Literature DB >> 24022532

Preoperative oral antibiotics and intravenous antimicrobial prophylaxis reduce the incidence of surgical site infections in patients with ulcerative colitis undergoing IPAA.

Tsutomu Oshima1, Yoshio Takesue, Hiroki Ikeuchi, Hiroki Matsuoka, Kazuhiko Nakajima, Motoi Uchino, Naohiro Tomita, Mitsuru Sasako.   

Abstract

BACKGROUND: The usefulness of preoperative oral antibiotics for the prevention of surgical site infection in elective colorectal surgery remains controversial.
OBJECTIVE: This study aimed to investigate the effects of oral antimicrobial prophylaxis in addition to intravenous antimicrobial prophylaxis on patients with ulcerative colitis undergoing restorative proctocolectomy.
DESIGN: This study was a randomized, nonblinded, single-center clinical trial.
SETTING: This study was conducted between July 1, 2006, and April 30, 2009, at Hyogo College of Medicine. PATIENTS: Two hundred patients with ulcerative colitis scheduled to undergo restorative proctocolectomy with IPAA with an open approach were randomly assigned to either group A or B (n = 100). Combined use of preoperative oral antibiotics and intravenous antimicrobial prophylaxis were given to group A, and intravenous antimicrobial prophylaxis alone was given to group B.
INTERVENTIONS: Patients in group A received oral antibiotics the day before surgery (500 mg of kanamycin and 500 mg of metronidazole at 2:00 P.M., 3:00 P.M., and 9:00 P.M.), whereas those in group B did not. All patients underwent preoperative mechanical bowel preparation, and intravenous antimicrobial prophylaxis with second-generation cephalosporin was given for 24 hours. MAIN OUTCOME MEASURES: The primary end point of this study was the incidence of overall surgical site infection according to intention-to-treat analysis.
RESULTS: The incidence of overall surgical site infection was significantly lower in group A (6/97 patients, 6.1%) than in group B (22/98 patients, 22.4%) (p = 0.0024). In multivariate analysis, the administration of oral antibiotics (OR, 0.178; 95% CI, 0.057-0.552; p = 0.003) and ASA score ≥3 (OR, 5.343; 95% CI, 1.595-17.891; p = 0.007) were independent risk factors for surgical site infection. LIMITATIONS: This study is limited because of its open-label nature.
CONCLUSIONS: Combined oral and intravenous antimicrobial prophylaxis in patients with ulcerative colitis undergoing restorative proctocolectomy with IPAA contributed to the prevention of surgical site infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24022532     DOI: 10.1097/DCR.0b013e31829f71a0

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  The role of oral antibiotics prophylaxis in prevention of surgical site infection in colorectal surgery.

Authors:  Michalis Koullouros; Nadir Khan; Emad H Aly
Journal:  Int J Colorectal Dis       Date:  2016-10-24       Impact factor: 2.571

2.  Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches.

Authors:  Jonathan J Hansen; R Balfour Sartor
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

3.  Oral antibiotics and a low-residue diet reduce the incidence of anastomotic leakage after left-sided colorectal surgery: a retrospective cohort study.

Authors:  Takafumi Nakazawa; Masashi Uchida; Takaaki Suzuki; Kohei Yamamoto; Kaori Yamazaki; Tetsuro Maruyama; Hideaki Miyauchi; Yuta Tsuruoka; Takako Nakamura; Yuki Shiko; Yohei Kawasaki; Hisahiro Matsubara; Itsuko Ishii
Journal:  Langenbecks Arch Surg       Date:  2022-06-06       Impact factor: 2.895

Review 4.  Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review.

Authors:  Marie Strøm Zangenberg; Nir Horesh; Uri Kopylov; Alaa El-Hussuna
Journal:  Int J Colorectal Dis       Date:  2017-10-19       Impact factor: 2.571

5.  The Role of Oral Antibiotic Preparation in Elective Colorectal Surgery: A Meta-analysis.

Authors:  Katie E Rollins; Hannah Javanmard-Emamghissi; Austin G Acheson; Dileep N Lobo
Journal:  Ann Surg       Date:  2019-07       Impact factor: 12.969

6.  Outcome of no oral antibiotic prophylaxis and bowel preparation in Crohn's diseases surgery.

Authors:  Lukas Walter Unger; Stefan Riss; Stanislaus Argeny; Michael Bergmann; Thomas Bachleitner-Hofmann; Friedrich Herbst; Anton Stift
Journal:  Wien Klin Wochenschr       Date:  2019-03-06       Impact factor: 1.704

7.  The Japan Society for Surgical Infection: guidelines for the prevention, detection, and management of gastroenterological surgical site infection, 2018.

Authors:  Hiroki Ohge; Toshihiko Mayumi; Seiji Haji; Yuichi Kitagawa; Masahiro Kobayashi; Motomu Kobayashi; Toru Mizuguchi; Yasuhiko Mohri; Fumie Sakamoto; Junzo Shimizu; Katsunori Suzuki; Motoi Uchino; Chizuru Yamashita; Masahiro Yoshida; Koichi Hirata; Yoshinobu Sumiyama; Shinya Kusachi
Journal:  Surg Today       Date:  2020-12-15       Impact factor: 2.549

8.  Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia.

Authors:  Josep M Badia; Miriam Flores-Yelamos; Ana Vázquez; Nares Arroyo-García; Mireia Puig-Asensio; David Parés; Miguel Pera; Joaquín López-Contreras; Enric Limón; Miquel Pujol
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

Review 9.  Meta-analysis of oral antibiotics, in combination with preoperative intravenous antibiotics and mechanical bowel preparation the day before surgery, compared with intravenous antibiotics and mechanical bowel preparation alone to reduce surgical-site infections in elective colorectal surgery.

Authors:  S T McSorley; C W Steele; A J McMahon
Journal:  BJS Open       Date:  2018-05-10

10.  Association of Mechanical Bowel Preparation and Oral Antibiotics Before Elective Colorectal Surgery With Surgical Site Infection: A Network Meta-analysis.

Authors:  James W T Toh; Kevin Phan; Kerry Hitos; Nimalan Pathma-Nathan; Toufic El-Khoury; Arthur J Richardson; Gary Morgan; Alexander Engel; Grahame Ctercteko
Journal:  JAMA Netw Open       Date:  2018-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.